{"version":"1.0","type":"link","title":"Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs. immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.","author_name":"Huang Z 외","author_url":"https://prs-insight.online/author/Huang%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/93805","thumbnail_width":1200,"thumbnail_height":630}